Causalien
Prime 8 ball Oracle
COVID-10 and Chloroquine
Did a pubmed search:
chloroquine covid-19 - PubMed - NCBI
10 results (that's not good - there should be much more if this worked)
From bottom to top (newest to oldest)
10 - This is an abstract (unpublished paper or poster) - it shows in vitro inhibition of infection into Vero E6 cell lines by therapeutic doses of Remdesivir and high doses of Chloroquine. Because this is an abstract, the authors have not made any comments on their data or conclusions. The data set is from a single set of experiments. This, however, is a very reputable journal.
9 - This is an editorial, not a research article. The authors report the in vitro data, and recommend follow up by randomized control trials. No treatment recommendation is made.
8 - Another editorial referencing back to the original Chinese clinical "trial" of 100 patients to which @bhzmark referred. No data presented.
7 - Additional editorial referencing back to original Chinese trial. No data presented.
6 - Unrelated article describing how to disseminate information from clinical trials. No data presented.
5 - Yet another editorial referencing back to original Chinese trial. No data presented.
4 - Review article - this is the best summary found to date of the history of chloroquine, the pros and cons, and the Chinese data, specifically this paragraph is a great primer:
"The in vitro antiviral activity of chloroquine has been identified since the late 1960's (Inglot, 1969; Miller and Lenard, 1981; Shimizu et al., 1972) and the growth of many different viruses can be inhibited in cell culture by both chloroquine and hydroxychloroquine, including the SARS coronavirus (Keyaerts et al., 2004). Some evidence for activity in mice has been found for a variety of viruses, including human coronavirus OC43 (Keyaerts et al., 2009), enterovirus EV-A71 (Tan et al., 2018), Zika virus (Li et al., 2017) and influenza A H5N1 (Yan et al., 2013). However, chloroquine did not prevent influenza infection in a randomized, double-blind, placebo-controlled clinical trial (Paton et al., 2011), and had no effect on dengue-infecteds patient in a randomized controlled trial in Vietnam (Tricou et al., 2010). Chloroquine was also active ex vivo but not in vivo in the case of ebolavirus in mice (Dowall et al., 2015; Falzarano et al., 2015), Nipah (Pallister et al., 2009) and influenza virus (Vigerust and McCullers, 2007) in ferrets."
The authors of #4 further go on to make the following statement:
"This would represent the first successful use of chloroquine in humans for the treatment of an acute viral disease, and is undoubtedly excellent news, since this drug is cheap and widely available. However, it should be considered carefully before drawing definitive conclusions, since no data has been provided yet to support this announcement."
BASICALLY - THE CHINESE SAY THEY HAVE DONE A TRIAL OF 100 PEOPLE, AND SEE SOME EFFECT, BUT HAVE NOT SHARED THEIR DATA. In the scientific community, not sharing your data so that others can reproduce your results is one of the biggest red flags there is. These authors call out the Chinese researchers on this:
"In conclusion, the option of using chloroquine in the treatment of SARS-CoV-2 should be examined with attention in light of the recent promising announcements, but also of the potential detrimental effect of the drug observed in previous attempts to treat acute viral diseases. We urge Chinese scientists to report the interim trial results currently running in China as soon as they are available. This should be preferentially done in a peer-reviewed publication with detailed information to allow the international scientific community to analyse the results, to confirm in prospective trials the efficacy of the proposed treatment and to guide future clinical practice."
3 - Yet another editorial referencing back to original Chinese trial.
2 - An in vitro study showing antiviral properties (we know this, nothing new is present here).
1 - These are the Chinese researchers making their recommendation for the use of Chloroquine, but they do not publish their actual data.
Does anyone have the ACTUAL original data from the Chinese researchers? Because everything I can find appears to go back to that one study of 100 patients, and then everyone is re-hashing the report and putting their own spin on it.
SHOW ME THE DATA!!!!
China has gone dark. They've ramped up their Internet army recently.
Try and look for the Hydroxychloroqin trials done in South Korea cause that's what they used.